ArticleJACC. CardioOncology2026

IL-6 in Checkpoint Myocarditis: A Promising Biomarker and Therapeutic Target.

Daniel A Zlotoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.